Diabetes Conference-NFOD 2026

Novel therapeutics in diabetes research are advancing rapidly, offering promising strategies to improve glycemic control, reduce complications, and enhance quality of life. Emerging drug classes, such as dual or triple agonists, SGLT2/GLP-1 combinations, and innovative insulin formulations, provide more effective and patient-friendly management options. Additionally, regenerative medicine approaches, including stem cell therapy and beta-cell replacement, aim to restore endogenous insulin production. Gene therapies targeting specific metabolic pathways are under investigation to address underlying disease mechanisms. By integrating these innovative therapies with lifestyle interventions and precision medicine approaches, healthcare providers can deliver highly personalized diabetes care, optimize metabolic outcomes, and transform long-term disease management.